MiniMed to Announce Its Fiscal Year 2027 Second Quarter Financial Results
MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that it expects to report financial results on Tuesday, November 24,…
Category
267 releases
MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that it expects to report financial results on Tuesday, November 24,…
Reports a 32% increase in operating income and consistent year-over-year revenue and Adjusted EBITDA1
Third Quarter Pre-Tax Income of $116 million
Russel Metals Inc. (TSX: RUS) announces financial results for three months ended September 30, 2026. Record Quarterly Revenues, Adjusted EBITDA and…
Third Quarter 2026 Net Income of $175.0 million or $0.85 per Diluted Share Third Quarter 2026 Adjusted Net Operating Income (Non-GAAP) of $174.7…
Delivered Third Quarter Net Sales of $147.6 Million, a 16.5% Increase Year-Over-Year
Grew total revenue to $151.8 million and testing revenue to $146.4 million, representing 15% year-over-year growth
Victory Capital Reports Strong Third Quarter 2026 Results, Highlighted by Record Gross Sales and Net Flows
Launched Niagen™ Plus Niagen™ Liquid At-Home Injections
Ribupatide oral global Phase 3 program expected to begin in 1H 2027 following completion of End-of-Phase 2 meeting with FDA
Relay Therapeutics Reports Third Quarter 2026 Financial Results and Corporate Updates
Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX: SVM) (NYSE American: SVM) is pleased to announce that its Board of Directors declared a…
Third Quarter 2026 Financial Results
PTC (NASDAQ: PTC) today reported financial results for its fourth fiscal quarter and full fiscal year ended September 30, 2026. Fourth Fiscal Quarter…
Solid Year-Over-Year Revenue Growth Driven by Consistent Production and Demand Expanded Product Offering with Recent Introduction of 65-ton Rotator…
Annual Recurring Revenue of $431 million, up 24% year-over-year
•Quarterly revenue of $88.2 million, representing an increase of 7% year-over-year